These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 12575970)
1. High-dose angiotensin-converting enzyme inhibition restores body fluid homeostasis in heart-transplant recipients. Braith RW; Mills RM; Wilcox CS; Davis GL; Hill JA; Wood CE J Am Coll Cardiol; 2003 Feb; 41(3):426-32. PubMed ID: 12575970 [TBL] [Abstract][Full Text] [Related]
2. High dose angiotensin-converting enzyme inhibition prevents fluid volume expansion in heart transplant recipients. Braith RW; Mills RM; Wilcox CS; Mitchell MJ; Hill JA; Wood CE J Am Coll Cardiol; 2000 Aug; 36(2):487-92. PubMed ID: 10933362 [TBL] [Abstract][Full Text] [Related]
3. Breakdown of blood pressure and body fluid homeostasis in heart transplant recipients. Braith RW; Mills RM; Wilcox CS; Davis GL; Wood CE J Am Coll Cardiol; 1996 Feb; 27(2):375-83. PubMed ID: 8557909 [TBL] [Abstract][Full Text] [Related]
4. Fluid homeostasis after heart transplantation: the role of cardiac denervation. Braith RW; Mills RM; Wilcox CS; Convertino VA; Davis GL; Limacher MC; Wood CE J Heart Lung Transplant; 1996 Sep; 15(9):872-80. PubMed ID: 8889982 [TBL] [Abstract][Full Text] [Related]
5. The renin angiotensin aldosterone system and frusemide response in congestive heart failure. Reed S; Greene P; Ryan T; Cerimele B; Schwertschlag U; Weinberger M; Voelker J Br J Clin Pharmacol; 1995 Jan; 39(1):51-7. PubMed ID: 7756099 [TBL] [Abstract][Full Text] [Related]
6. Differential effects of captopril and enalapril on tissue renin-angiotensin systems in experimental heart failure. Hirsch AT; Talsness CE; Smith AD; Schunkert H; Ingelfinger JR; Dzau VJ Circulation; 1992 Nov; 86(5):1566-74. PubMed ID: 1330361 [TBL] [Abstract][Full Text] [Related]
7. Additive effects of combined angiotensin-converting enzyme inhibition and angiotensin II antagonism on blood pressure and renin release in sodium-depleted normotensives. Azizi M; Chatellier G; Guyene TT; Murieta-Geoffroy D; Ménard J Circulation; 1995 Aug; 92(4):825-34. PubMed ID: 7641363 [TBL] [Abstract][Full Text] [Related]
8. Effects of Dietary Sodium Restriction in Kidney Transplant Recipients Treated With Renin-Angiotensin-Aldosterone System Blockade: A Randomized Clinical Trial. de Vries LV; Dobrowolski LC; van den Bosch JJ; Riphagen IJ; Krediet CT; Bemelman FJ; Bakker SJ; Navis G Am J Kidney Dis; 2016 Jun; 67(6):936-44. PubMed ID: 26803690 [TBL] [Abstract][Full Text] [Related]
9. Urocortin 2 combined with angiotensin-converting enzyme inhibition in experimental heart failure. Rademaker MT; Charles CJ; Nicholls MG; Richards AM Clin Sci (Lond); 2008 May; 114(10):635-42. PubMed ID: 18052934 [TBL] [Abstract][Full Text] [Related]
10. Resistant Hypertension On Treatment (ResHypOT): sequential nephron blockade compared to dual blockade of the renin-angiotensin-aldosterone system plus bisoprolol in the treatment of resistant arterial hypertension - study protocol for a randomized controlled trial. Cestário EDES; Fernandes LAB; Giollo-Júnior LT; Uyemura JRR; Matarucco CSS; Landim MIP; Cosenso-Martin LN; Tácito LHB; Moreno H; Vilela-Martin JF; Yugar-Toledo JC Trials; 2018 Feb; 19(1):101. PubMed ID: 29433578 [TBL] [Abstract][Full Text] [Related]
11. Neurohormonal reactivation in heart failure patients on chronic ACE inhibitor therapy: a longitudinal study. Lee AF; MacFadyen RJ; Struthers AD Eur J Heart Fail; 1999 Dec; 1(4):401-6. PubMed ID: 10937954 [TBL] [Abstract][Full Text] [Related]
12. Effects of captopril on renal functions, renal and portal hemodynamics in patients with cirrhosis. Tsai YT; Lin HC; Lee FY; Hou MC; Wang SS; Lee SD Proc Natl Sci Counc Repub China B; 1996 Apr; 20(2):44-50. PubMed ID: 8931343 [TBL] [Abstract][Full Text] [Related]
13. Significance of kallikrein-kinin and renin-angiotensin systems in the hypotensive mechanism of angiotensin-I converting enzyme inhibitors in essential hypertensives. Iimura O; Shimamoto K Adv Exp Med Biol; 1989; 247A():39-48. PubMed ID: 2532450 [TBL] [Abstract][Full Text] [Related]
14. Acute hemodynamic effects of drugs acting on the renin-angiotensin system in acute heart failure. Nekooeian AA; Ogilvie RI; Zborowska-Sluis D Can J Cardiol; 1995 Jan; 11(1):59-64. PubMed ID: 7850666 [TBL] [Abstract][Full Text] [Related]
16. Participation of the renin system in treatment-resistant hypertension as measured by acute blockade of the angiotensin converting enzyme. Weber MA; Drayer JI; Priest RT; Chen TC Am J Nephrol; 1982; 2(1):6-11. PubMed ID: 6295161 [TBL] [Abstract][Full Text] [Related]
17. Converting enzyme inhibition with captopril abolishes sympathoexcitation to euglycemic hyperinsulinemia in rats. Muntzel MS; Morales J; Akinsefunmi A Am J Hypertens; 2001 Jun; 14(6 Pt 1):592-8. PubMed ID: 11411741 [TBL] [Abstract][Full Text] [Related]
18. Lifetime treatment with captopril improves renal function in spontaneously hypertensive rats. Roysommuti S; Mozaffari MS; Berecek KH; Wyss JM Clin Exp Hypertens; 1999 Nov; 21(8):1315-25. PubMed ID: 10574415 [TBL] [Abstract][Full Text] [Related]
19. Blood pressure control by the renin-angiotensin system in normotensive subjects. Assessment by angiotensin converting enzyme and renin inhibition. Kiowski W; Linder L; Kleinbloesem C; van Brummelen P; Bühler FR Circulation; 1992 Jan; 85(1):1-8. PubMed ID: 1728438 [TBL] [Abstract][Full Text] [Related]
20. Captopril in clinical hypertension. Changes in components of renin-angiotensin system and in body composition in relation to fall in blood pressure with a note on measurement of angiotensin II during converting enzyme inhibition. Atkinson AB; Morton JJ; Brown JJ; Davies DL; Fraser R; Kelly P; Leckie B; Lever AF; Robertson JI Br Heart J; 1980 Sep; 44(3):290-6. PubMed ID: 7000102 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]